Sequence of events in the glomerular capillary wall at the onset of proteinuria in passive Heymann nephritis

2001 ◽  
Vol 438 (2) ◽  
pp. 136-145 ◽  
Author(s):  
Yoshihide Fujigaki ◽  
Stephen Batsford ◽  
Fuyuki Yamashita ◽  
Katsuhiko Yonemura ◽  
Akira Hishida ◽  
...  
1999 ◽  
Vol 10 (8) ◽  
pp. 1689-1699 ◽  
Author(s):  
C. J. ILSE RAATS ◽  
MARIKEN E. LUCA ◽  
MARINKA A. H. BAKKER ◽  
ANNEMIEKE VAN DER WAL ◽  
PETER HEERINGA ◽  
...  

Abstract. In a time-study of active Heymann nephritis, the expression of agrin, the main heparan sulfate proteoglycan in the glomerular basement membrane, was analyzed in relation to deposition of IgG and complement in the glomerular capillary wall and the development of albuminuria. Binding of IgG autoantibodies to the glomerular capillary wall could be detected from 2 wk onward, followed by activation of complement after 6 wk. Progressive albuminuria developed from 6 wk onward to a level of 274 ± 68 mg/18 h at week 12. The staining intensity for the agrin core protein decreased slightly, and the staining intensity for the heparan sulfate stubs that were still attached to the core protein after heparitinase digestion remained normal. From week 6 onward, however, a progressive decrease was seen in the staining of two monoclonal antibodies (mAb) directed against different epitopes on the heparan sulfate polysaccharide side chain of agrin (to 35 and 30% of the control level, respectively, at week 12, both mAb P = 0.016). Moreover, albuminuria was inversely correlated with heparan sulfate staining as revealed by these antibodies (rs = -0.82 and rs = -0.75, respectively, both mAb P < 0.0001). This decrease in heparan sulfate staining was due to a progressive reduction of glomerular heparan sulfate content to 46 and 32% of control level at week 10 and week 12 of the disease, respectively, as measured biochemically. It is speculated that the observed decrease in glomerular heparan sulfate in active Heymann nephritis is due to complement-mediated cleavage of heparan sulfate, resulting in an increased permeability of the glomerular basement membrane to macromolecules.


1975 ◽  
Vol 51 (3) ◽  
pp. 354-376 ◽  
Author(s):  
Harrison Latta ◽  
William H. Johnston ◽  
Thomas M. Stanley

Nephron ◽  
1992 ◽  
Vol 62 (4) ◽  
pp. 382-388 ◽  
Author(s):  
Alberto Baraldi ◽  
Luciana Furci ◽  
Giovanna Zambruno ◽  
Elisabetta Rubbiani ◽  
Giorgio Annessi ◽  
...  

Author(s):  
Hernán Trimarchi ◽  
Rosanna Coppo

Abstract Immunoglobulin A nephropathy (IgAN) is considered as mesangiopathy since it initiates in the mesangium; however, other glomerular components are involved and the glomerular capillary wall offers the first contact to circulating macromolecular IgA1. Acute and active forms of IgAN are associated with endocapillary hypercellularity and vascular damage of various degrees, in severe cases with microangiopathy (MA) without or with thrombosis [thrombotic microangiopathy (TMA)]. Vascular damage activates complement and coagulation cascades. A defective complement regulation has recently been detected in active and progressive cases of IgAN. C4d deposits in renal biopsies have been found to be an early risk factor. These observations have raised interest in manifestation of MA and TMA in progressive cases of IgAN. MA–TMA lesions have been found in various percentages (2–53%) of patients with IgAN according to patients’ selection and pathology definition of TMA. The association with hypertension (HTN) was so strong that it led to the hypothesis that MA/TMA in IgAN was a mere consequence of severe HTN. Old and new clinical and experimental data indicate that in IgAN the interaction of the glomerular capillary wall with immune reactants and complement uncontrolled activation leading to C4b deposits favours the development of MA–TMA, which plays a role in progression and renal function decline. The central role of complement activation is relevant also for the new therapeutic interventions offered by the pharma.


Sign in / Sign up

Export Citation Format

Share Document